IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma
Authors
Keywords
-
Journal
ONCOGENE
Volume 37, Issue 7, Pages 873-883
Publisher
Springer Nature
Online
2017-10-24
DOI
10.1038/onc.2017.387
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor microenvironment-mediated chemoresistance in breast cancer
- (2016) Kobra velaei et al. BREAST
- Survival and Proliferation of Neural Progenitor–Derived Glioblastomas Under Hypoxic Stress is Controlled by a CXCL12/CXCR4 Autocrine-Positive Feedback Mechanism
- (2016) Anda-Alexandra Calinescu et al. CLINICAL CANCER RESEARCH
- Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis
- (2016) Bodo E. Lippitz et al. OncoImmunology
- Molecular mechanisms of chemoresistance in gastric cancer
- (2016) Wen-Jia Shi et al. World Journal of Gastrointestinal Oncology
- CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma
- (2015) Masakazu Goto et al. ANNALS OF SURGICAL ONCOLOGY
- CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer
- (2015) Y-C Wu et al. ONCOGENE
- ABCB5 Maintains Melanoma-Initiating Cells through a Proinflammatory Cytokine Signaling Circuit
- (2014) B. J. Wilson et al. CANCER RESEARCH
- Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression
- (2014) J. L. Heinecke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Comprehensive Analysis of CXCL12 Isoforms in Breast Cancer1,2
- (2014) Shuang Zhao et al. Translational Oncology
- CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression
- (2014) L Lin et al. Cell Death & Disease
- Estrogen represses CXCR7 gene expression by inhibiting the recruitment of NFκB transcription factor at the CXCR7 promoter in breast cancer cells
- (2013) Gwenneg Kerdivel et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma
- (2013) H. K. Bid et al. CLINICAL CANCER RESEARCH
- CXCR7 expression in esophageal cancer
- (2013) Michael Tachezy et al. Journal of Translational Medicine
- The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma
- (2013) Lin Zhang et al. Journal of Translational Medicine
- Oesophageal carcinoma
- (2013) Arjun Pennathur et al. LANCET
- The role of tumour–stromal interactions in modifying drug response: challenges and opportunities
- (2013) Douglas W. McMillin et al. NATURE REVIEWS DRUG DISCOVERY
- Oesophageal cancer—an overview
- (2013) Michael Schweigert et al. Nature Reviews Gastroenterology & Hepatology
- Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases
- (2013) M. Gil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stuck in the middle of chemoresistance and metastasis
- (2012) M. Teresa Villanueva Nature Reviews Clinical Oncology
- PDGF-D Improves Drug Delivery and Efficacy via Vascular Normalization, But Promotes Lymphatic Metastasis by Activating CXCR4 in Breast Cancer
- (2011) J. Liu et al. CLINICAL CANCER RESEARCH
- CXCL12 (SDF1 )-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?
- (2011) D. G. Duda et al. CLINICAL CANCER RESEARCH
- Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
- (2011) H. Korkaya et al. CLINICAL CANCER RESEARCH
- The chemokine system and cancer
- (2011) Frances R Balkwill JOURNAL OF PATHOLOGY
- CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
- (2010) Xueqing Sun et al. CANCER AND METASTASIS REVIEWS
- The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects
- (2010) K. Hattermann et al. CANCER RESEARCH
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- CXCR7: a new SDF-1-binding receptor in contrast to normal CD34+ progenitors is functional and is expressed at higher level in human malignant hematopoietic cells
- (2010) Maciej Tarnowski et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Regulation of Expression of Stromal-Derived Factor-1 Receptors: CXCR4 and CXCR7 in Human Rhabdomyosarcomas
- (2010) M. Tarnowski et al. MOLECULAR CANCER RESEARCH
- Autocrine TGF- and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts
- (2010) Y. Kojima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interaction between BCL2 and Interleukin-10 Gene Polymorphisms Alter Outcomes of Diffuse Large B-Cell Lymphoma following Rituximab Plus CHOP Chemotherapy
- (2009) Y. H. Park et al. CLINICAL CANCER RESEARCH
- CXCR7 is inducible by HTLV-1 Tax and promotes growth and survival of HTLV-1-infected T cells
- (2009) Zhe Jin et al. INTERNATIONAL JOURNAL OF CANCER
- The role of CXC chemokines and their receptors in cancer
- (2008) Jo Vandercappellen et al. CANCER LETTERS
- Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain
- (2008) Cimona V. Hinton et al. CLINICAL & EXPERIMENTAL METASTASIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started